Bio Similars/Subsequent Entry Biologic Report

Bio Similars/Subsequent Entry Biologic Report

By www.reliablemarketsize.com

Report Details


Report Name

Global And United States Bio Similars/Subsequent Entry Biologic Market Report & Forecast 2023-2028 Story

Pages

119

Price

$ 4350

Features


Bio Similars/Subsequent Entry Biologic Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered


              Sun Pharma
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen idec
Genentech (Roche)
Pfizer
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG
AbbVie
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3sbio
Biotech
Gelgen
Innovent
Dong Bao
Ganlee